Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissues

3 Aug 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 37537298
DOI: 10.1038/s43018-023-00608-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissuesPMID 37537298Read ↗

Lighting up cancer initiation with mutant p53 reporters.Semantic proximity Read ↗

Cancer-Associated Mutations but No Cancer: Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer DetectionSemantic proximity Read ↗

Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53Semantic proximity Read ↗

Molecular pathology in basal cell cancer with p53 as a genetic markerSemantic proximity Read ↗

Precancer Atlas to Drive Precision Prevention Trials.Semantic proximity Read ↗

ΔNp63α in cancer: importance and therapeutic opportunitiesSemantic proximity Read ↗

Tumour biology: Policing of oncogene activity by p53.Semantic proximity Read ↗

Mutant p53 Gain-of-Function in the Spotlight: Are We Suffering a GOF Delusion?Semantic proximity Read ↗

A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.Semantic proximity Read ↗

Dormant tumor-suppressor pathways in tumors.Semantic proximity Read ↗

Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.Semantic proximity Read ↗

Falling out of the fold: tumorigenic mutations and p53.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.